UPDATE: Cytosorbents (CTSO) Tops Q2 EPS View
(Updated - August 14, 2015 8:01 AM EDT) (EPS corrected)
Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of $0.05, which was better than the analyst estimate of ($0.11). Revenue for the quarter came in at $733 thousand versus the consensus estimate of $910 thousand.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.